NeoGenomics to Participate in Upcoming Investor Conferences
NeoGenomics to Present RaDaR ST Bridging Study at ISLB 2025, Demonstrating Reliable MRD Detection Across Solid Tumors
NeoGenomics Reports Third Quarter 2025 Results